European Oncology and Haematology : Impact Factor & More
eISSN: 2045-5283pISSN: 2045-5275
Share this on:
Key Metrics
CiteScore 
0.5
H-Index
8
SJR
Q4Oncology
SNIP
0.12
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
European Oncology and Haematology Journal Specifications
Indexed in the following public directories
SJR
| Overview | |
| Publisher | Touch Digital Media |
Planning to publish in European Oncology and Haematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Oncology and Haematology
Immunotherapy in Advanced Prostate Cancer
- 1 Jan 2020
- European Oncology & Haematology
Thromboprophylaxis – A Neglected Front in Hospitalised Patients with COVID-19 in Pakistan
- 1 Jan 2020
- European Oncology & Haematology
Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy
- 1 Jan 2020
- European Oncology & Haematology
Luspatercept for Beta-thalassemia – A New Horizon?
- 1 Jan 2020
- European Oncology & Haematology
Regorafenib – Five Years in Review
- 1 Jan 2020
- European Oncology & Haematology
Development of<i>HER2</i>-targeted Therapies for Gastrointestinal Cancer
- 1 Jan 2020
- European Oncology & Haematology
Immunotherapy in Advanced Prostate Cancer
- 1 Jan 2020
- European Oncology & Haematology
Thromboprophylaxis – A Neglected Front in Hospitalised Patients with COVID-19 in Pakistan
- 1 Jan 2020
- European Oncology & Haematology
Facing the First-line in Metastatic Non-small-cell Lung Cancer – Immunotherapy and Chemotherapy
- 1 Jan 2020
- European Oncology & Haematology
Luspatercept for Beta-thalassemia – A New Horizon?
- 1 Jan 2020
- European Oncology & Haematology
Regorafenib – Five Years in Review
- 1 Jan 2020
- European Oncology & Haematology
Development of<i>HER2</i>-targeted Therapies for Gastrointestinal Cancer
- 1 Jan 2020
- European Oncology & Haematology
FAQs on European Oncology and Haematology
How many articles did European Oncology and Haematology publish last year? 
What is the eISSN & pISSN for European Oncology and Haematology?
What is Citescore for European Oncology and Haematology?
What is the H Index for European Oncology and Haematology ?
What is SNIP score for European Oncology and Haematology?
What is the SJR for European Oncology and Haematology?
Who is the publisher of European Oncology and Haematology?
